Literature DB >> 20503045

The diagnostic accuracy of 18F-FDG PET in cutaneous malignant melanoma.

Bruno Krug, Anne-Sophie Pirson, Ralph Crott, Thierry Vander Borght.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20503045     DOI： 10.1007/s00259-010-1475-4

Source DB:  PubMed          Journal:  Eur J Nucl Med Mol Imaging        ISSN： 1619-7070            Impact factor:   9.236


× No keyword cloud information.
  17 in total

Review 1.  Development and validation of methods for assessing the quality of diagnostic accuracy studies.

Authors:  P Whiting; A W S Rutjes; J Dinnes; J Reitsma; P M M Bossuyt; J Kleijnen
Journal:  Health Technol Assess       Date:  2004-06       Impact factor: 4.014

2.  Assessment of the accuracy of diagnostic tests: the cross-sectional study.

Authors:  J A Knottnerus; J W Muris
Journal:  J Clin Epidemiol       Date:  2003-11       Impact factor: 6.437

3.  Level of fluorodeoxyglucose uptake predicts risk for recurrence in melanoma patients presenting with lymph node metastases.

Authors:  Esther Bastiaannet; Otto S Hoekstra; Wim J G Oyen; Piet L Jager; Theo Wobbes; Harald J Hoekstra
Journal:  Ann Surg Oncol       Date:  2006-05-23       Impact factor: 5.344

4.  Routine use of FDG-PET scans in melanoma patients with positive sentinel node biopsy.

Authors:  Janne Horn; Jørgen Lock-Andersen; Helle Sjøstrand; Annika Loft
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-04-04       Impact factor: 9.236

5.  Cost-effectiveness analysis of FDG PET-CT in the management of pulmonary metastases from malignant melanoma.

Authors:  Bruno Krug; Ralph Crott; Isabelle Roch; Max Lonneux; Claire Beguin; Jean-François Baurain; Anne-Sophie Pirson; Thierry Vander Borght
Journal:  Acta Oncol       Date:  2010       Impact factor: 4.089

6.  Futility of fluorodeoxyglucose F 18 positron emission tomography in initial evaluation of patients with T2 to T4 melanoma.

Authors:  Paige B Clark; Victoria Soo; Jonathan Kraas; Perry Shen; Edward A Levine
Journal:  Arch Surg       Date:  2006-03

Review 7.  Role of PET in the initial staging of cutaneous malignant melanoma: systematic review.

Authors:  Bruno Krug; Ralph Crott; Max Lonneux; Jean-François Baurain; Anne-Sophie Pirson; Thierry Vander Borght
Journal:  Radiology       Date:  2008-12       Impact factor: 11.105

8.  Meta-analysis of the performance of (18)F-FDG PET in cutaneous melanoma.

Authors:  Felisa Jiménez-Requena; Roberto C Delgado-Bolton; Cristina Fernández-Pérez; Sanjiv S Gambhir; Judy Schwimmer; José M Pérez-Vázquez; José L Carreras-Delgado
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-09-02       Impact factor: 9.236

9.  Conducting systematic reviews of diagnostic studies: didactic guidelines.

Authors:  Walter L Devillé; Frank Buntinx; Lex M Bouter; Victor M Montori; Henrica C W de Vet; Danielle A W M van der Windt; P Dick Bezemer
Journal:  BMC Med Res Methodol       Date:  2002-07-03       Impact factor: 4.615

10.  The development of QUADAS: a tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews.

Authors:  Penny Whiting; Anne W S Rutjes; Johannes B Reitsma; Patrick M M Bossuyt; Jos Kleijnen
Journal:  BMC Med Res Methodol       Date:  2003-11-10       Impact factor: 4.615
View more
  1 in total

1.  Gene therapy for advanced melanoma: selective targeting and therapeutic nucleic acids.

Authors:  Joana R Viola; Diana F Rafael; Ernst Wagner; Robert Besch; Manfred Ogris
Journal:  J Drug Deliv       Date:  2013-03-25
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.